Cisplatin decreases cyclin D2 expression via upregulating miR‑93 to inhibit lung adenocarcinoma cell growth-Reference-Cited by-同舟云学术

Cisplatin decreases cyclin D2 expression via upregulating miR‑93 to inhibit lung adenocarcinoma cell growth

Published:2019-08-06 Issue: Volume: Page:
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Report

Author:

Xie Ning¹,Liu Yuan‑Rong²,Li Yan‑Mei¹,Yang Ya‑Nan²,Pan Li²,Wei Yu‑Bo²,Wang Ping‑Yu²,Li You‑Jie²,Xie Shu‑Yang²

Affiliation:

1. Department of Chest Surgery, Yantaishan Hospital, Yantai, Shandong 264000, P.R. China

2. Department of Biochemistry and Molecular Biology, Key Laboratory of Tumor Molecular Biology in Binzhou Medical University, Binzhou Medical University, Yantai, Shandong 264003, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scanning ion conductance microscopy revealed cisplatin-induced morphological changes related to apoptosis in single adenocarcinoma cells;Analytical Methods;2024

2. Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Non-Small Cell Lung Cancer Preclinical Models;International Journal of Molecular Sciences;2022-07-25

3. LncRNAs and miRNAs participate in determination of sensitivity of cancer cells to cisplatin;Experimental and Molecular Pathology;2021-12

4. A review on the role of oncogenic lncRNA OIP5-AS1 in human malignancies;Biomedicine & Pharmacotherapy;2021-05

5. Reactive Pt(II) center as part of redox-active quinoline-based heterocyclic scaffolds toward new anticancer leads;Bioorganic & Medicinal Chemistry Letters;2020-11